r Natriuretic peptides are powerful regulators of the cardiovascular system, but their direct electrophysiological effects in the heart are poorly understood.
Introduction
Natriuretic peptides (NPs) are powerful and important regulators of the cardiovascular system. These peptide hormones, including atrial (ANP), B-type (BNP) and C-type (CNP) NPs, are best known for their ability to regulate blood volume and blood pressure by causing natriuresis and diuresis as well as by controlling vascular tone (Levin et al. 1998; Kuhn, 2004; Potter et al. 2006) . By regulating these critical physiological parameters NPs can importantly regulate cardiac output by affecting loading conditions on the heart. More recently, it has become apparent that NPs can also have direct effects on ion channels in the heart, including in the sinoatrial node (SAN). We have demonstrated that BNP and CNP can potently modulate action potential profiles and ion channels in SAN and atrial myocytes (Rose et al. 2004; Azer et al. 2012; Springer et al. 2012) . These direct electrophysiological effects of NPs in the SAN result in changes in heart rate, which is also a critical determinant of cardiac output.
NPs elicit their effects by binding to specific NP receptors denoted NPR-A, NPR-B and NPR-C (Anand-Srivastava & Trachte, 1993; Lucas et al. 2000; Potter et al. 2006) . NPR-A is activated by ANP and BNP while NPR-B is activated by CNP. Each of these receptors is associated with a membrane-bound guanylyl cyclase (GC) enzyme that increases the production of cyclic GMP (cGMP) when a peptide is bound. The NPR-C receptor is not directly associated with GC enzymes. Rather, NPR-C, which binds all NPs with similar affinity, activates inhibitory G-proteins (G i ) and reduces intracellular cyclic AMP (cAMP) levels (Anand-Srivastava et al. 1996; Pagano & Anand-Srivastava, 2001; Zhou & Murthy, 2003; Rose & Giles, 2008) . We have shown that all three NPRs are expressed in the SAN and atrial myocardium and, depending on experimental conditions, can contribute to the regulation of ion channels in SAN and atrial myocytes. Specifically, we have demonstrated that NPR-A and NPR-B cause increases in heart rate, whereas NPR-C mediates a reduction in heart rate. (Rose et al. 2004; Azer et al. 2012; Springer et al. 2012) .
The SAN is a highly specialized and complex structure with a unique physiology compared to the surrounding atrial myocardium (Keith & Flack, 1907; Boyett et al. 2000; James, 2002 James, , 2003 Liu et al. 2007; Fedorov et al. 2012) . Pacemaker myocytes are distributed throughout the right atrial posterior wall in the region between the superior vena cava and the inferior vena cava (Boineau et al. 1988; Boyett et al. 2000; Dobrzynski et al. 2005) . Changes in heart rate are known to be associated with changes in the region of the SAN exhibiting the dominant frequency of spontaneous activity (Boineau et al. 1988; Fedorov et al. 2012) . To study SAN activation patterns and how electrical signals propagate within the SAN and from the SAN to the surrounding atrial myocardium one must use high-resolution optical mapping (Efimov et al. 2004; Herron et al. 2012) . A major advantage of this technique is that it permits simultaneous measurement of activation patterns, electrical conduction and action potential morphology in a multicellular preparation.
In the present study we have used optical mapping techniques to study the effects of BNP and CNP on electrical conduction in the SAN and atrial myocardium. By using BNP (which binds NPR-A and NPR-C) and CNP (binds NPR-B and NPR-C) as agonists we were able to determine the roles of all three NPRs in different experimental conditions. Understanding how NPs affect electrical conduction within the specialized SAN and into the working atrial myocardium is essential because NPs are currently in use (Lee & Burnett, 2007) or in development (Rose, 2010) for the treatment of heart failure. Our data provide the first detailed description of how distinct NPRs determine the effects of NPs on activation patterns and electrical conduction within the SAN and atrial myocardium.
been backcrossed into the C56Bl/6 line for more than 15 generations. All experiments involving animals were in accordance with the regulations of the Canadian Council on Animal Care and were approved by The Dalhousie University Committee on Laboratory Animals.
Atrial preparation
A typical experimental preparation consisting of the SAN and surrounding atrial tissues is shown in Fig. 1 . To isolate this preparation mice were administered a 0.2 ml intraperitoneal injection of heparin (1000 IU ml −1 ) to prevent blood clotting and were then anaesthetized by isoflurane inhalation and cervically dislocated. Hearts were rapidly excised into Krebs solution (35°C) containing (in mM): 118 NaCl, 4.7 KCl, 1.2 KH 2 PO 4 , 12.2 MgSO 4 , 1 CaCl 2 , 25 NaHCO 3 and 11 glucose. This Krebs solution was bubbled with 95% O 2 /5% CO 2 to maintain a pH of 7.4. The atria were dissected away from the ventricles and pinned in a dish with the endocardial surface facing upwards (towards the imaging equipment). The superior and inferior vena cavae were cut open so that the crista terminalis could be visualized. The SAN area is located in the intercaval region in the right atrial posterior wall adjacent to the crista terminalis (Mangoni & Nargeot, 2001; Verheijck et al. 2001; Liu et al. 2007; Azer et al. 2012; Springer et al. 2012) .
The SAN/atrial preparation was superfused continuously with Krebs solution (35°C) bubbled with 95% O 2 /5% CO 2 and allowed to equilibrate for at least 30 min. During this time the preparation was treated with the voltage-sensitive dye di-4-ANEPPS (10 μM) for ß15 min and blebbistatin (10 μM) was added to the superfusate to suppress contractile activity (Fedorov et al. 2007; Farman et al. 2008; Lou et al. 2012) . Blebbistatin was present throughout the duration of the experiments to prevent motion artifacts during optical mapping, which is necessary to measure optical action potentials. Most experiments were performed in sinus rhythm so that the cycle length (i.e. heart rate) of the atrial preparation was free to change. In a subset of studies we used a unipolar pacing electrode to pace atrial preparations at a fixed cycle length of 90 ms to study effects of pharmacological compounds on electrical conduction independently of changes in cycle length. This cycle length was chosen so that we would be able effectively to capture the preparations in all conditions, including in isoproterenol, which potently increases heart rate. When used, the pacing electrode was placed near the opening of the superior vena cava.
Optical mapping and data analysis
Optical signals from atrial preparations containing the SAN were measured using procedures similar to those we have described previously (Rose et al. 2011) . Specifically, di-4-ANEPPS-loaded atrial preparations were illuminated with light at a wavelength of 520-570 nm using an EXFO X-cite fluorescent light source (Lumen Dynamics, Mississauga, Ontario, Canada). Emitted fluorescent light (590-640 nm) was captured using a high speed EMCCD camera (Evolve 128, Photometrics, Tucson, AZ, USA). This camera contains a 128 × 128 pixel array and, in our experimental setup, each pixel measured 77 × 77 μm, which results in a maximum field of view on the atrial preparation of ß10 × 10 mm. Magnification was constant in all experiments and no pixel binning was used; thus, this pixel size remained constant in all measurements. Data were captured at a frame rate of ß1000 frames s -1 using Metamorph software (Molecular Devices, Sunnyvale, CA, USA).
All optical data were analysed using custom software written in Matlab. Analyses included pseudocolour electrical activation maps and isochronal contour plots, which were generated from measurements of activation time at individual pixels. In all cases background fluorescence was subtracted. In some experiments we also generated optical action potential (OAP) data by measuring the change in fluorescence as a function of time at individual pixels at specific locations in the preparation including in the SAN (initial exit site in the intercaval region of the right atrial posterior wall) and in the working right atrial myocardium (measured in the right atrial appendage, RAA). OAP measurements were used to quantify action potential duration in the SAN and right atrium as well as the slope of the diastolic depolarization (DD) in the SAN. Action potential duration and DD slope measurements were averages from 8-10 consecutive OAPs in a given condition at each location. DD slope was measured by fitting this phase with a straight line and determining its slope, which we quantified as a relative change in fluorescence units per ms ( F ms -1 ) . No attempt was made to calibrate changes in fluorescence to voltage measurements. Only relative changes in fluorescence were assessed before and after application of pharmacological compounds. OAPs were low pass filtered to reduce noise. Local conduction velocity (CV) was quantified specifically in the SAN (at the site of initial breakthrough), right atrial myocardium (within the RAA), or left atrial myocardium (at the border of left atrial appendage) using an established approach previously described (Morley et al. 1999; Nygren et al. 2004) . Briefly, activation times at each pixel from a 7 × 7 pixel array were determined and fit to a plane using the least squares fit method. The direction on this plane that is increasing the fastest represents the direction that is perpendicular to the wavefront of electrical propagation and the maximal slope represents the inverse of the speed of conduction in that direction. Thus, using this method, we computed maximum local CV vectors in the atrial region of interest. 
Statistical analysis
All summary data are presented as means ± SEM. Data were analysed using a paired Student's t-test or one-way analysis of variance (ANOVA) with Tukey's post hoc analysis. P < 0.05 was considered significant.
Results

Optical mapping of atrial preparations containing the SAN
Initially, we sought to confirm the stability of our atrial preparations during optical mapping studies. This was done by first measuring the effects of blebbistatin (10 μM) on electrical conduction and cycle length in atrial preparations stained with di-4-ANNEPS (Supplemental Fig.   Figure 1 . Mouse atrial preparation used for optical mapping experiments The preparation is orientated so that the right atrium is on the right side of the image. RAA, right atrial appendage; CT, crista terminalis; SVC, opening of superior vena cava; IVC, opening of inferior vena cava; IAS, interatrial septum; LAA, left atrial appendage. The sinoatrial node is located in the intercaval region adjacent to the CT. The white oval on the left side of the CT indicates the typical location of first electrical breakthrough in the sinoatrial node within the right atrial posterior wall. 1). These data demonstrate that blebbistatin had no effect on activation pattern, SAN CV (5.9 ± 0.2 vs. 5.7 ± 0.2 cm s −1 ; P = 0.374) or cycle length (142.4 ± 3.9 vs. 142 ± 4.1 ms; P = 0.698) based on measurements in control conditions and after 45 min of blebbistatin treatment. Next, we measured cycle length in the presence of blebbistatin every 5 min for 45 min (Supplemental Fig.  1D ). These data show that cycle length (i.e. heart rate) remained very stable (ß140 ms) for at least 45 min.
To study and compare the effects of natriuretic peptides on SAN and atrial conduction it was essential to confirm our ability to optically map the SAN region in our mouse atrial preparations. Representative activation maps in control conditions demonstrate that the site of initial electrical breakthrough in the SAN was located in the right atrial posterior wall adjacent to the crista terminalis. We refer to this site as the 'initial exit site' in the SAN (as opposed to 'leading pacemaker site') due to the three-dimensional nature of electrical propagation in the SAN and surrounding atrial myocardium as well as the presence of preferential conduction pathways within the heterogeneous SAN region of the heart (Fedorov et al. 2012) . In control conditions this initial exit site was somewhat variable. In the majority of preparations it was located towards the superior region of the preparation (e.g. Fig. 2A and D) , but in some cases was located in the inferior region of the preparation (see Fig. 4A ). This is comparable to previous studies demonstrating that the SAN can extend from the superior vena cava to the inferior cava in mice Boyett et al. 2000; Liu et al. 2007) . Despite the variability in location from superior to inferior the initial exit site was always in the intercaval region of the right atrium adjacent to the crista terminalis, as expected for the mammalian heart (Verheijck et al. 2001; Nygren et al. 2004; Fedorov et al. 2006; Liu et al. 2007; Glukhov et al. 2010) . From the initial exit site, electrical activity spread to the rest of the atrial tissues. Propagation into the right atrial appendage was uniform and radial. Conversely, a block zone (Boyett et al. 2000; Fedorov et al. 2012) , in which propagation was slowed towards the atrial septum, was typically seen on the left side of the initial exit site (see Fig. 2A and D for examples). This block zone is evident from the crowding of contour lines to the left of the initial exit site in colour maps and resulted in propagation toward the left atrium occurring preferentially via the inferior region of the preparation.
Effects of NPs on electrical activity in basal conditions
Initial NP experiments measured the effects of BNP, CNP and cANF (50-500 nM) on electrical conduction in the right atrial posterior wall, including the SAN region, in basal conditions. These measurements were performed in atrial preparations in sinus rhythm. The partially . In these and all subsequent figures the right atrial appendage is on the right side of the image. Red colour indicates earliest activation time (ms) within the right atrial posterior wall. C, application of BNP caused a superior shift in initial exit site within the SAN. D and E, representative colour maps showing activation patterns in control conditions and after application of the NPR-C agonist cANF (500 nM). F, application of cANF had no effect on initial exit site in basal conditions. G, summary of the effects of BNP, CNP and cANF (500 nM each) on conduction velocity in the leading pacemaker site. H, summary of the effects of BNP, CNP and cANF (500 nM) on cycle length. I, summary of the effect of BNP (50 nM) on conduction velocity in the leading pacemaker site. J, summary of the effects of BNP (50 nM) on cycle length. Time interval between isochrones in activation maps is 1.1 ms. * P < 0.05 vs. control by one-way ANOVA with Tukey's post hoc test; n = 7 hearts each for the BNP and CNP groups and n = 5 hearts for the cANF group. ring-deleted peptide cANF is a selective agonist of NPR-C (Anand- Srivastava et al. 1990; Rose & Giles, 2008) . Representative activation maps ( Fig. 2A and B) demonstrate that BNP sped conduction (note fewer isochrones and increased distance between isochrones in the presence of BNP) in association with a superior shift in the initial exit site (Fig. 2C ). On average BNP increased (P < 0.05) CV in the initial exit site from 6.7 ± 0.2 to 9.7 ± 0.4 cm s −1 (Fig. 2G ). BNP also shortened (P < 0.05) cycle length from 149 ± 4.8 to 121.7 ± 6.5 ms (Fig. 2H) . CNP (500 nM) elicited very similar increases (P < 0.05) in CV in the initial exit site (6.2 ± 0.2 cm s −1 in control vs. 9.8 ± 0.4 cm s −1 ; Fig. 2G ) and decreases (P < 0.05) in cycle length (152.4 ± 6.2 ms in control vs. 119.6 ± 6.3 ms in CNP; Fig. 2H ). The superior shift in initial exit site was observed in all hearts treated with BNP or CNP (14 hearts in total). Furthermore, we did not observe beat to beat variations in initial exit site in control conditions or after application of NPs. We also measured the effects of a lower dose of BNP (50 nM) on SAN CV and cycle length. At this dose BNP was nearly as effective as the higher dose, whereby CV was increased (P < 0.05) from 5.8 ± 0.2 to 7.4 ± 0.1 cm s −1 (Fig. 2I ) and cycle length was decreased (P < 0.05) from 175 ± 8.1 to 157 ± 7.5 ms (Fig. 2J ). The effects of BNP and CNP on SAN activation patterns, initial exit site and CV were fully reversible on washout ( Fig. 2G-J) .
In contrast to BNP and CNP, cANF (500 nM) had no effect on activation pattern ( Fig. 2D and E) or location of the initial exit site in the right atrial posterior wall (Fig. 2F ). Average CVs were 6.3 ± 0.2 cm s −1 in control and 6.2 ± 0.2 cm s −1 after application of cANF ( Fig. 2G ; P = 0.85) while cycle length was 151.3 ± 5.2 ms in control and 147 ± 5.7 ms in cANF ( Fig. 2J ; P = 0.99). Note that the CVs measured in the SAN (Fig. 2 ) are relatively low, as expected, and very comparable in magnitude to those reported by others Verheijck et al. 2001; Fedorov et al. 2006) .
To further evaluate the effects of NPs on SAN activity in basal conditions we measured OAPs from the leading activation site following application of BNP, CNP and cANF (500 nM). Representative spontaneous OAPs from the SAN are illustrated in control conditions and following application of BNP (500 nM; Fig. 3A ) or cANF (500 nM; Fig. 3B ). As expected for the SAN, action potentials from this location were always characterized by the presence of a DD phase between successive spontaneous action potentials (see Methods). BNP increased (P < 0.05) the DD slope from 0.03 ± 0.001 to 0.06 ± 0.003 F ms −1 (Fig. 3C) , which resulted in a shortening of the diastolic interval between successive OAPs (Fig. 3A) . Similarly, CNP increased (P < 0.05) the DD slope from 0.04 ± 0.002 to 0.07 ± 0.003 F ms −1 (Fig. 3C ). The NPR-C agonist cANF, on the other hand, had no effect (P = 0.74) on DD slope (0.032 ± 0.002 F ms −1 vs. 0.031 ± 0.002 F ms −1 ; Fig. 3C ) and OAPs overlapped (Fig. 3B) .
We also analysed the effects of BNP, CNP and cANF on OAP duration at 50% (APD 50 ) and 90% (APD 90 ) repolarization in basal conditions ( Fig. 3D and E). BNP and CNP each increased (P < 0.05) APD 50 (46.6 ± 0.9 ms in control vs. 53.4 ± 1.1 ms in BNP; 47.4 ± 0.5 ms in control vs. 55 ± 0.3 ms in CNP) and APD 90 (68.6 ± 1.2 ms in control vs. 74.8 ± 1.1 ms in BNP; 70.6 ms in control vs. 77.8 ± 0.9 ms in CNP). Conversely, cANF had no effect (P = 0.18) on APD 50 (47.2 ± 0.5 vs. 47.6 ± 0.5 ms) or APD 90 (73 ± 0.6 vs. 73.2 ± 0.5 ms).
Next, the effects of BNP, CNP and cANF (50-500 nM) on conduction into the right atrial appendage in basal conditions were measured in atrial preparations in sinus rhythm (Fig. 4) . Representative activation maps ( Fig. 4A and B) illustrate the pattern of electrical propagation from initial exit site into the right atrial appendage in control conditions and after application of BNP. In this example, the initial exit site in control conditions was located on the inferior side of the preparation. BNP again shifted the initial exit site in the superior direction and sped conduction into the right atrium. On average, BNP (500 nM) increased (P < 0.05) CV in the right atrial appendage from 35.3 ± 0.4 to 42.5 ± 1.4 cm s −1 . CNP (500 nM) had very similar effects to BNP and increased (P < 0.05) atrial CV from 36.3 ± 0.8 to 41.3 ± 0.7 cm s −1 (Fig. 4E ). The lower dose of BNP (50 nM) increased (P < 0.05) atrial CV from 37.2 ± 1.9 to 43 ± 1.1 cm s −1 , further demonstrating that the low dose of BNP is almost as effective as the higher dose.
Representative activation maps illustrating the effects of cANF on conduction in the right atrial appendage are shown in Fig. 4C and D. These examples focused specifically on the atrial appendage, and the initial exit site within the right atrial posterior wall is outside the field of view. Consistent with the absence of effects of cANF in the SAN in basal conditions (Fig. 2 ) activation pattern and conduction time into the right atrial appendage were unaffected by cANF. Right atrial CV was unaltered (P = 0.94) following application of cANF (38 ± 0.2 vs. 38.1 ± 0.2 cm s −1 ). Note that these right atrial CVs are consistent with prior studies (Nygren et al. 2004; Swaminathan et al. 2011) and are much faster than those measured in the SAN.
The effects of BNP, CNP and cANF on action potential duration in basal conditions in the right atrium were also measured. Representative recordings from the right atrial appendage (Fig. 4G) demonstrate that, in contrast to the SAN, atrial OAPs have stable resting membrane potentials. Furthermore, summary data demonstrate that APD 50 (Fig. 4H ) and APD 90 (Fig. 4J ) values in the right atrium in control conditions are shorter than those in the SAN (compare to Fig. 3D and E) . These observations are consistent with prior studies (Boyett et al. 2000; Nygren et al. 2004; Fedorov et al. 2006; Springer et al. 2012) and further confirm our ability to accurately and distinctly map the SAN and atrial myocardium. On average, neither BNP (P = 0.38), CNP (P = 0.18) nor cANF (P = 0.37) had any effect on right atrial action potential duration in these conditions.
Effects of NPs on electrical conduction in basal conditions in paced atrial preparations
The above experiments demonstrate that, in basal conditions, BNP and CNP potently decrease cycle length (i.e. increase heart rate), which is consistent with our recent findings in isolated hearts and SAN myocytes Springer et al. 2012) . To determine if the effects of NPs on activation patterns and electrical conduction are independent of changes in cycle length we measured the effects of CNP (50 nM) in atrial preparations paced at a fixed cycle length of 90 ms (see Methods). These data (Fig. 5 ) demonstrate that CNP increased (P < 0.05) SAN CV from 6.1 ± 0.2 to 7.2 ± 0.2 cm s −1 , independently of a change in cycle length. The magnitude of this increase (ß15%) was smaller than that seen with application of the same dose of BNP (50 nM) in atrial preparations in sinus rhythm (ß30%) where cycle length was free to change, indicating that the effects of NPs on SAN CV in basal conditions are partially independent of cycle length. In contrast, although there was a trend toward a small increase in right atrial CV following application of CNP in paced atrial preparations (40.1 ± 1.7 cm s −1 in control vs. 43 ± 1.4 cm s −1 after CNP) this did not reach statistical significance (P = 0.1). In these experiments using paced atrial preparations we also measured left atrial CV. Similarly to the right atrium, there was a trend towards a small increase in left atrial CV (42.6 ± 1.6 cm s −1 in control vs. 46.1 ± 2 cm s −1 in CNP) that did not reach statistical significance (P = 0.13). These data suggest that the increases in right atrial CV seen in atrial preparations in sinus rhythm (in basal conditions) are primarily rate dependent.
Effects of BNP on electrical conduction in the SAN and right atrium following NPR-A blockade
The observations that BNP and CNP increase conduction in the SAN and right atrium in basal conditions, but that the NPR-C agonist cANF has no effect on conduction in these conditions, suggests that the effects of BNP and CNP are mediated by NPR-A and NPR-B, respectively. To evaluate this hypothesis we measured the effects of BNP (500 nM) in the presence of the NPR-A antagonist A71915 (500 nM) (Delporte et al. 1992) . Representative activation maps (Fig. 6A ) illustrate the effects of A71915 and BNP on electrical conduction in the right atrial posterior wall and into the right atrial appendage. Neither A71915 nor BNP elicited any alterations in conduction time or initial exit site within the right atrial posterior wall. Average SAN CVs were 6.4 ± 0.1 cm s −1 in control, 6.6 ± 0.1 cm s −1 after application of A71915 and 6.5 ± 0.1 cm s −1 after application of BNP in the presence of A71915 (Fig. 6B ). These data demonstrate that A71915 itself has no effect (P = 0.56) on SAN conduction velocity and, furthermore, the effects of BNP were completely antagonized (P = 0.56) following NPR-A blockade. Similar findings were observed in the right atrium. Specifically, CV in the right atrial appendage was 39 ± 0.6 cm s −1 in control conditions, 39 ± 1.1 cm s
in the presence of A71915 and 39.5 ± 1.1 cm s −1 after application of BNP in the presence of A71915 (Fig. 6C ). These data demonstrate that the stimulatory effects of BNP on CV in the SAN and right atrium are NPR-A dependent (see Discussion). Effects of NPs on electrical activity in the SAN and right atrium in the presence of the β-adrenergic receptor agonist ISO We have previously shown that NPR-C can mediate effects of NPs following activation of the β-adrenergic receptors (β-ARs) with ISO (Rose et al. 2004; Azer et al. 2012) ; therefore, the next series of experiments compared the effects of BNP, CNP and cANF (50-500 nM) on activation patterns and electrical conduction in the SAN and right atrium in the presence of ISO (1 μM). Representative activation maps (Fig. 7A-C) illustrate the patterns of electrical conduction in the right atrial posterior wall in control conditions, in the presence of ISO and after application of CNP in the presence of ISO. ISO consistently shifted the initial exit site in the superior direction (Fig. 7D ) and sped conduction from this site through the right atrial posterior wall. Subsequent application of CNP counteracted the effects of ISO by slowing conduction and shifting the initial exit site in the inferior direction back toward that seen in control conditions (Fig. 7D) . On average, SAN CV was increased (P < 0.05) from 5.8 ± 0.1 cm s −1 in control to 8.9 ± 0.2 cm s −1 in ISO. Application of BNP (500 nM) in the presence of ISO reduced (P < 0.05) SAN CV to 7.3 ± 0.2 cm s −1 (Fig. 7I ).
CNP (500 nM) had very comparable effects on SAN CV (4.9 ± 0.2 cm s −1 in control, 9.1 ± 0.4 cm s −1 in ISO, 7.8 ± 0.1 cm s −1 in ISO + CNP; P < 0.05; Fig. 7I ). These changes in SAN CV occurred in association with changes in cycle length (Fig. 7J) . ISO shortened cycle length (P < 0.05), as expected. Subsequent application of BNP or CNP opposed the effects of ISO and resulted in comparable increases (P < 0.05) in cycle length.
Representative activation maps illustrating the effects of selective NPR-C activation with cANF in the presence of ISO in the right atrial posterior wall are presented in Fig. 7E -G. Again, ISO shifted the initial exit site in the superior direction (Fig. 7H) and sped electrical conduction out of this site. cANF opposed this ISO effect by shifting the initial exit site back in the inferior direction and slowing conduction. Summary data (Fig. 7J ) demonstrate that SAN CV was increased (P < 0.05) from 6.0 ± 0.2 cm s −1 in control to 9.0 ± 0.1 cm s −1 in the presence of ISO. Subsequent application of cANF decreased (P < 0.05) SAN CV to 6.3 ± 0.2 cm s −1 . On average, BNP and CNP (in the presence of ISO) similarly reduced SAN CV by 18 and 14%, respectively. In contrast, the reduction in SAN CV following selective activation of NPR-C with cANF in the presence of ISO was 30%, an effect that was larger (P < 0.05) than the effects of BNP and CNP. ISO and cANF also induced changes in cycle length. Specifically, ISO shortened cycle length from 144.1 ± 8.2 to 105.2 ± 3.9 ms. Subsequent application of cANF increased cycle length to 139.5 ± 8.2 ms. The increase in cycle length (in the presence of ISO) elicited by cANF (ß25%) was larger (P < 0.05) than the increases elicited by BNP (ß11%) and CNP (ß10%).
Finally, we measured the effects of lower 50 nM doses of cANF on SAN CV (Fig. 7K ) and cycle length (Fig. 7L) . On average, SAN CV was increased (P < 0.05) from 5.5 ± 0.1 cm s −1 in control to 8.2 ± 0.1 cm s −1 in ISO. Subsequent application of cANF (50 nM) reduced (P < 0.05) CV to 7.1 ± 0.2 cm s −1 . Cycle length was reduced (P < 0.05) from 143 ± 15.5 ms in control to 92 ± 7.7 ms in ISO. Application of cANF (50 nM) in the presence of ISO increased (P < 0.05) cycle length to 106 ± 6.2 ms.
The effects of BNP, CNP and cANF (500 nM) on OAPs from the SAN in the presence of ISO (1 μM) are presented in Fig. 8 . Representative SAN OAPs (Fig. 8A ) in control conditions, in ISO and following application of CNP in the presence of ISO demonstrate changes in DD slope and action potential duration following treatment with these compounds, which resulted in clear changes in the diastolic interval between subsequent action potentials. Summary data (Fig. 8B ) demonstrate that DD slope was increased (P < 0.05) from 0.05 ± 0.003 F ms −1 in control conditions to 0.12 ± 0.006 F ms −1 . Application of CNP (in the presence of ISO) reduced (P < 0.05) DD slope to 0.1 ± 0.003 F ms −1 . BNP had very similar effects on DD slope in SAN OAPs (0.048 ± 0.002 F ms −1 in control conditions, 0.098 ± 0.002 F ms −1 in ISO, 0.077 ± 0.003 F ms −1 after BNP; P < 0.05, Fig. 8B ). Selective activation of NPR-C with cANF in the presence of ISO reduced (P < 0.05) DD slope from 0.11 ± 0.004 to 0.06 ± 0.003 F ms −1 . The average reductions in DD slope (in the presence of ISO) were 21 and 17% for BNP and CNP, respectively. In contrast, cANF caused a larger (P < 0.05) reduction in DD slope of 45%.
The effects of BNP, CNP and cANF on APD 50 and APD 90 are illustrated in Fig. 8C and D. As expected, ISO increased APD 50 and APD 90 in the SAN. Summary data further demonstrate that BNP, CNP and cANF all opposed this effect of ISO and decreased (P < 0.05) APD 50 and APD 90 . The percentage reductions in AP duration were similar (P = 0.37) for all three peptides. Figure 9 demonstrates the effects of BNP, CNP and cANF (50-500 nM) on electrical conduction into the right atrial appendage in the presence of ISO (1 μM). Representative activation maps (Fig. 9A-C) illustrate that ISO speeds conduction from the initial exit site into the right atrial appendage and that subsequent application of CNP opposes this effect of ISO. Consistent with our earlier findings (Fig. 7) , ISO shifted the initial exit site in the superior direction while CNP (in the presence of ISO) shifted the initial exit site inferiorly. Average CVs in the right atrial appendage were increased (P < 0.05) from 37.5 ± 0.6 cm s (1 μM; B) , and following application of CNP (500 nM) in the presence of ISO (C). Time interval between isochrones is 1 ms. D, location of the initial exit site in the right atrial posterior wall in control, ISO and ISO + CNP. E-H, representative colour maps and shifts in initial exit site within the SAN are illustrated in control conditions, in the presence of ISO (1 μM), and following application of cANF in the presence of ISO. Time interval between isochrones is 1 ms. I, summary of the effects of BNP, CNP and cANF (500 nM each) on conduction velocity in the SAN leading pacemaker site in the presence of ISO. J, summary of the effects of BNP, CNP and cANF (500 nM) on cycle length in the presence of ISO. K, summary of the effects of the NPR-C agonist cANF (50 nM) on conduction velocity in the SAN in the presence of ISO. L, summary of the effects of cANF (50 nM) on cycle length in the presence of ISO. * P < 0.05 vs. control; + P < 0.05 vs. ISO by one-way ANOVA with a Tukey post hoc test; n = 6 hearts for BNP, n = 7 hearts for CNP and n = 7 hearts for cANF. (Fig. 9G) . BNP elicited very similar changes in right atrial conduction velocity (Fig. 9G) .
Representative activation maps showing the effects of ISO and cANF specifically in the right atrial appendage (initial exit site not shown) are presented in Fig. 9D-F . In these experiments right atrial CV was increased (P < 0.05) from 36.9 ± 0.4 cm s −1 in control to 45.4 ± 0.5 cm s −1 in ISO. Subsequent application of cANF decreased (P < 0.05) CV to 37.9 ± 0.4 cm s −1 (Fig. 9G) . Average reductions in right atrial CV elicited by BNP and CNP were 7 and 11%, respectively. Selective activation of NPR-C with cANF elicited a larger (P < 0.05) 17% reduction in right atrial CV. We also measured the effects of a lower dose of cANF (50 nM) on right atrial CV in the presence of ISO (Fig. 9H) . At this dose cANF reduced (P < 0.05) ISO stimulated CV from 45.4 ± 1.0 to 42 ± 0.7 cm s −1 . The effects of BNP, CNP and cANF (500 nM) on right atrial action potential duration are presented in Fig. 9I -K. Representative right atrial OAPs (Fig. 9I) demonstrate APs with stable resting membrane potentials in control conditions, in the presence of ISO and following application of CNP in the presence of ISO. Summary data in Fig. 9J and K illustrate that ISO increased (P < 0.05) APD 50 and APD 90 in the right atrium. In contrast to basal conditions (Fig. 4) BNP, CNP and cANF each elicited reductions (P < 0.05) in APD 50 and APD 90 in the presence of ISO. The magnitude of the reductions in AP duration were similar (P = 0.83) for all three peptides.
Effects of NPs on electrical activity in the presence of ISO in paced atrial preparations
Next, we measured the effects cANF (50 nM) on electrical conduction in atrial preparations paced at a fixed cycle length (90 ms) to assess the effects of selective NPR-C activation independently of changes in cycle length. In these experiments (Fig. 10A ) ISO increased (P < 0.05) SAN CV from 5.7 ± 0.1 to 8 cm s −1 . Subsequent application of cANF decreased SAN CV to 7.2 ± 0.2 cm s −1 . Right atrial CV (Fig. 10B ) was increased (P < 0.05) from 35.6 ± 1.3 to 43 ± 0.8 cm s −1 in ISO. Application of cANF in the presence of ISO decreased (P < 0.05) right atrial CV to 40.6 ± 1.2 cm s −1 . Together, these data demonstrate that, in the presence of ISO, NPs can decrease SAN and right atrial CV independently of changes in cycle length. We also measured changes in left atrial CV in these experiments. Similarly to the right atrium, ISO increased (P < 0.05) left atrial CV in paced atrial preparation from 36 ± 2.6 to 43.5 ± 1.7 cm s −1 . Subsequent application of cANF modestly reduced (P = 0.41) left atrial CV to 41.5 ± 1.5 cm s −1 . The inhibitory effects of cANF on SAN and right atrial conduction are blocked by the NPR-C antagonist AP-811
Our data clearly demonstrate that cANF causes a slowing of conduction in the SAN and right atrium when applied in the presence of ISO. To definitively prove the role of NPR-C in mediating this effect we utilized a potent peptide inhibitor of NPR-C, AP-811 (Veale et al. 2000; William et al. 2008) . Figure 11A illustrates representative activation maps (from initial exit site through the right atrial posterior wall and into the right atrial appendage) in control conditions, in the presence of ISO (1 μM), after application of AP-811 (100 nM), and finally upon application of cANF (500 nM) in the presence of ISO and AP-811. Summary data (Fig. 11B) demonstrate that, as expected, ISO increased (P < 0.05) SAN CV from 4.9 ± 0.2 to 9.2 ± 0.2 cm s −1 . Application of AP-811 to block NPR-C had no effect (P = 0.99) on its own on SAN CV (9.2 ± 0.2 cm s −1 ). Subsequent application of cANF in the presence of AP-811 also had no effect (P = 0.98) on SAN CV, which remained at 9.1 ± 0.2 cm s −1 . Similar effects were observed in the right atrial appendage whereby the effects of cANF on right atrial CV were complete blocked by AP-811 (Fig. 11C ). These findings demonstrate that cANF slows CV in the SAN and atrial myocardium by activating NPR-C.
Effects of BNP on SAN and right atrial conduction in NPR-C
−/− hearts Native NPs, including BNP and CNP, are able to bind their guanylyl cyclase-linked NPR-A and NPR-B receptors as well as NPR-C (Potter et al. 2006 ). Our data demonstrate that in basal conditions, BNP and CNP increase conduction in the SAN and atria via the NPR-A/B receptors. In contrast, in the presence of ISO, BNP and CNP switch to eliciting decreases in conduction; however, the magnitude of these decreases is not as large as those observed when NPR-C is selectively activated with cANF. Accordingly, we hypothesized that, in the presence of ISO, BNP and CNP activate multiple receptors simultaneously and that NPR-C activation opposes the effects mediated by NPR-A and NPR-B. To test this hypothesis we measured the effects of ISO (1 μM) and BNP (500 nM) on SAN and right atrial conduction in NPR-C −/− hearts (Fig. 12) . Without functional NPR-C receptors we hypothesized that BNP would only be able to activate NPR-A and would elicit a further increase (rather than a decrease) in conduction in the presence of ISO.
Representative activation maps (Fig. 12A ) and summary data ( Fig. 12B and C) demonstrate that, in NPR-C −/− hearts, BNP speeds, rather than slows, conduction in the presence of ISO. ISO increased (P < 0.05) SAN CV from 6.2 ± 0.2 to 8.4 ± 0.1 cm s −1 . Subsequent application of BNP further increased (P < 0.05) SAN CV to 11.3 ± 0.4 cm s −1 (Fig. 12B) . Similar observations were made in the right atrial appendage of NPR-C −/− hearts, where CV was increased (P < 0.05) from 34.3 ± 0.5 to 38.8 ± 0.6 cm s −1 by ISO and further increased (P < 0.05) to 42.5 ± 0.6 cm s −1 upon application of BNP in the presence of ISO (Fig. 12C ). These data demonstrate that NPR-C is responsible for the inhibitory effects of NPs in the presence of ISO and that the GC-linked NPRs as well as NPR-C contribute to the effects of NPs during β-AR activation.
Discussion
We have used high-resolution optical mapping to study the effects of NPs on electrical conduction in the specialized pacemaker tissues of the SAN as well as in the atrial myocardium. Using this approach we were able to precisely and definitively map electrical activation in the SAN and distinguish it from the surrounding atrial myocardium. Specifically, we consistently observed the first electrical activation was located in the intercaval region of the right atrial posterior wall, adjacent to the crista terminalis, which corresponds to the SAN region as described anatomically in the mouse heart (Liu et al. 2007; Fedorov et al. 2012) . Baseline CVs in the SAN were low (i.e. <10 cm s −1 ) in comparison to the surrounding working atrial myocardium. OAPs measured in the leading pacemaker site always displayed DDs between successive action potentials and were characterized by their relatively long duration in comparison to working atrial OAPs, which always had stable resting membrane potentials and relatively short durations. All of these observations are consistent with prior studies from several other groups using a number of mammalian species including mice, rabbits, dogs and humans Boyett et al. 2000; Verheijck et al. 2001; Nygren et al. 2004; Fedorov et al. 2006 Fedorov et al. , 2009 2010a; 2010b) .
The experiments performed in this study have generated highly novel insight into the complex effects of NPs in the heart, including in the SAN. Our data demonstrate (500 nM each) on right atrial conduction velocity in the presence of ISO. H, summary of the effects of cANF (50 nM) on right atrial conduction velocity in the presence of ISO. I, representative optical action potentials in the right atrial appendage in control conditions, in the presence of ISO (1 μM) and after application of CNP (500 nM) in the presence of ISO. J and K, summary data illustrating the effects of BNP, CNP and cANF (500 nM each) on APD 50 and APD 90 . * P < 0.05 vs. control; + P < 0.05 vs. ISO by one-way ANOVA with a Tukey post hoc test; n = 6 hearts for BNP, n = 7 hearts for CNP and n = 7 hearts for cANF. that NPs have potent, condition-specific effects on the location of initial exit site in right atrial posterior wall, CV and action potential morphology in the SAN and atria. These NP effects on electrical conduction involve multiple NPRs. Consistent with this, we have recently demonstrated that all three NPRs are expressed in the SAN and atrial myocardium (Springer et al. 2012) . In basal conditions, the effects of BNP and CNP were mediated exclusively by NPR-A and NPR-B (i.e. the GC-linked NPRs). Evidence for this conclusion includes the findings that the effects of BNP were completely antagonized by the NPR-A antagonist A71915 (Delporte et al. 1992) and that the NPR-C selective agonist cANF has no effect on electrical conduction in basal conditions. Thus, NPR-C does not appear to play a functional role in basal conditions, which is consistent with our prior studies in isolated hearts and myocytes Springer et al. 2012) .
In the presence of ISO, which increased CV as expected (Fedorov et al. 2010a) , BNP and CNP decreased, rather than increased, conduction in the SAN and atrial myocardium. Application of cANF, which only activates NPR-C, also reduced SAN and atrial conduction in the presence of ISO indicating that NPR-C is responsible for these inhibitory effects of NPs. This was confirmed with the use of AP-811, an NPR-C antagonist (Veale et al. 2000) that completely blocked the inhibitory effects of cANF on activation pattern and conduction in the SAN and atrial myocardium. The inhibitory effects of cANF on CV in the SAN and right atrium were significantly larger than those of the native peptides BNP and CNP. We hypothesized that this was because BNP and CNP can simultaneously activate their GC-linked NPRs (which mediate an increase in CV) as well as NPR-C (which mediates a decrease in CV), resulting in opposing effects mediated by these distinct NPRs. Accordingly, we measured the effects of BNP in hearts from NPR-C −/− mice in the presence of ISO. We found that the inhibitory effects of BNP on CV were absent in NPR-C −/− hearts and, in fact, BNP elicited a further increase in CV presumably mediated by NPR-A (the only remaining receptor sensitive to BNP). Taken together, our data demonstrate that NPs increase CV in the SAN and atrial myocardium via the NPR-A and NPR-B receptors while NPR-C mediates decreases in CV, particularly in the presence of enhanced β-AR signalling. In the presence of ISO both of these pathways contribute to the effects of NPs with the overall effect being a decrease in CV.
The effects of BNP and CNP on electrical conduction in basal conditions and in the presence of ISO were associated with respective increases or decreases in cycle length. These changes in cycle length were highly consistent with changes in heart rate (measured via electrogram recordings in isolated hearts) and spontaneous action potential frequency (measured in isolated SAN myocytes) that we have recently described (Rose et al. 2004; Azer et al. 2012; Springer et al. 2012 ).
Our present experiments clearly demonstrate that these effects are associated with shifts in the initial exit site in the right atrial posterior wall, suggesting that this is an important mechanism by which NPs affect heart rate and SAN function. We also measured the effects of NPs in externally paced atrial preparations to determine their effects on electrical conduction independently of changes in heart rate. These novel experiments demonstrate that NPs affect SAN CV even without a change in cycle length, although the effects were not as large as those observed when cycle length also changed. This suggests that the effects of NPs on SAN CV are partially independent of heart rate. Interestingly, in basal conditions, atrial CVs were increased by BNP and CNP in atrial preparations in sinus rhythm, but not in paced preparations. This indicates that, in these conditions, the effects of NPs on atrial CV are largely rate dependent. In contrast, right atrial CV was reduced by NPs in the presence of ISO in paced preparations.
Together, these studies indicate that NPs require adenylyl cyclase activation to elicit direct effects on electrical conduction in the working atrial myocardium, as we have previously shown for ion channels in isolated atrial myocytes (Springer et al. 2012) . The SAN, on the other hand, has been shown to have a high level of constitutive adenylyl cyclase activity (Vinogradova et al. 2006) , which could partly explain the potent effects of NPs in the SAN in basal conditions. The ways in which the three NPRs work together to determine the overall effects of NPs have been very poorly understood; however, the experiments in the present study along with our prior work in isolated hearts and myocytes Springer et al. 2012) provide important new insight into this complex issue. Numerous studies have shown that the autonomic nervous system controls heart rate and SAN function in association with changes in initial exit site (or leading pacemaker site as it is often denoted) (Bouman et al. 1968; Mackaay et al. 1980; Schuessler et al. 1986; Kodama et al. 1996; Beaulieu et al. 1997; Vinogradova et al. 1998; Fedorov et al. 2006 Fedorov et al. , 2010a Glukhov et al. 2010) . Specifically, the parasympathetic nervous system slows spontaneous activity in the SAN and shifts the initial exit site inferiorly while the sympathetic nervous system speeds spontaneous activity in the SAN and shifts the initial exit site in the superior direction. It is interesting that changes in electrical conduction following application of NPs were also associated with shifts in the location of the initial exit site in the right atrial posterior wall. In basal conditions, BNP and CNP consistently shifted the initial exit site in the superior direction; this effect is analogous to the effects of ISO (i.e. sympathetic nervous system activation) in the SAN (Fedorov et al. 2010a; Glukhov et al. 2010) . Consistent with this, we have previously shown that the effects of NPs on heart rate and ionic currents in the SAN in basal conditions, which are mediated by NPR-A and NPR-B, involve a downstream inhibition of phosphodiesterase 3 (PDE3) Springer et al. 2012) . Like ISO, inhibition of PDE3 would be expected to result in an increase in cAMP-dependent signalling. On the other hand, in the presence of ISO (which induced the expected superior shift in leading pacemaker site), BNP, CNP and cANF slow electrical conduction in association with inferior shifts in leading pacemaker site. These inhibitory effects of NPs are mediated by NPR-C. The parasympathetic nervous system also inhibits SAN function in association with inferior shifts in leading pacemaker site (Vinogradova et al. 1998; Fedorov et al. 2006; Glukhov et al. 2010 ) via activation of muscarinic (M 2 ) receptors. Interestingly, both M 2 receptors and NPR-C signal in the heart via pertussis toxin-sensitive G i proteins that lead to a reduction in cAMP levels (Anand-Srivastava et al. 1996; Pagano & Anand-Srivastava, 2001; Zhou & Murthy, 2003; Rose et al. 2004) . A previous study (Beaulieu et al. 1997) did show that CNP can elicit positive chronotropic effects in canines; however, using electrode mapping, this study did not detect a change in leading pacemaker site after application of CNP. This may be related to differences in experimental approach (i.e. using electrodes to map activation in comparison to the high-resolution optical approach we have employed in our study). Thus, our data show, for the first time, that depending on which NPRs are activated in different conditions, NPs can affect spontaneous SAN activation and location of the initial exit site in ways similar to the sympathetic or parasympathetic branches of the autonomic nervous system.
CV is affected by a number of parameters, including action potential upstroke velocity and cell to cell communication via gap junctions (Boyett et al. 2000; Kleber & Rudy, 2004) . Action potential upstroke velocity, and thus CV, is heavily dependent on Na + current (I Na ) density in working cardiomyocytes. Recently, it has been demonstrated that I Na is also present (at much lower densities) in SAN myocytes and that the Na V 1.5 isoform in particular plays an important role in conduction of electrical signals from the SAN to the atrial myocardium (Lei et al. 2004 . We have previously demonstrated that NPs elicit effects on ion channels in SAN myocytes via effects on cAMP (Rose et al. 2004; Azer et al. 2012; Springer et al. 2012) . Na + channels have been reported to be modulated by cAMP (Matsuda et al. 1992; Cantrell et al. 2002) ; however, the effects of NPs on I Na in SAN myocytes have not been studied. Future studies will assess this possibility and whether effects of NPs on I Na could explain changes in conduction velocity in SAN and atrial myocardium. In SAN myocytes, L-type Ca 2+ current (I Ca,L ) plays an important role in determining the action potential upstroke and thus may be a contributing factor to the slow conduction velocities typical of SAN myocytes (Kleber & Rudy, 2004) . We have previously shown that I Ca,L is a critical target of NP signalling downstream of NPR-A/B and NPR-C in SAN and working cardiomyocytes (Rose et al. 2003 (Rose et al. , 2004 Rose & Giles, 2008; Springer et al. 2012) ; thus, effects on I Ca,L probably play an important role in the effects of NPs on conduction in the SAN. The effects of NPs and their receptors on gap junction function have not been investigated.
ANP, the third member of the NP family, also plays a critical role in cardiovascular physiology and homeostasis (Levin et al. 1998; Potter et al. 2006) . ANP binds to NPR-A and NPR-C, similarly to BNP (Potter et al. 2006) . Based on this, it seems reasonable to hypothesize that ANP would have comparable effects on electrical conduction in the SAN and atria to those we have demonstrated for BNP. Very little is known about the direct effects of ANP on SAN function; however, some studies have demonstrated that ANP can increase the beating rate of isolated atrial preparations (Herring et al. 2001 ) while other studies report no effect of ANP on heart rate (Beaulieu et al. 1996; Hirose et al. 1998) . Future studies will be needed to clarify the specific effects of ANP on SAN function and determine how they compare to the effects of BNP and CNP we have measured in the present study. Some limitations should be considered when interpreting the results of our study. We have used di-4-ANEPPS to measure changes in voltage. di-4-ANEPPS can have some direct transient effects on the heart (Fedorov et al. 2006) ; however, it is widely used for the kinds of applications used in our study (Herron et al. 2012) . Blebbistatin was used to suppress motion, which is necessary to accurately assess action potential morphology optically. Several studies have demonstrated that blebbistatin is highly effective at preventing contraction without disrupting ion channels, action potential morphology or activation patterns (Fedorov et al. 2007; Lou et al. 2012) . Consistent with these reports, our present experiments also show that blebbistatin has no effect on activation pattern, SAN CV or cycle length. One recent report, however, does suggest that blebbistatin may have direct effects on cardiac electrophysiology, including action potential duration (Brack et al. 2013) . This indicates there may be a need to further evaluate the use of blebbistatin as a mechanical uncoupler in optical mapping experiments. We have measured CVs using a well-established method that produces a local maximum CV measurement (Morley et al. 1999; Nygren et al. 2004) . Recent studies, however, have demonstrated that CV in the SAN is heterogeneous and anisotropic (Fedorov et al. 2006; Fedorov et al. 2012) . Our measurements do not account for the anisotropic nature of CV in the SAN. Nevertheless, our method very effectively enables assessment of changes in local CV before and after application of pharmacological compounds. Finally, our assessment of DD slope from OAPs can only be quantified as a relative change in fluorescence. Because OAPs represent measurements from more than one cell, changes in AP morphology must be interpreted cautiously. Nevertheless, numerous studies have demonstrated that changes in AP morphology can be assessed optically, particularly when measuring the acute effects of pharmacological compounds in the same preparation (Nygren et al. 2004; Fedorov et al. 2010a) . Importantly, the relative changes in DD slope and AP duration we have observed following application of NPs in our optical mapping studies are very comparable to those we have measured quantitatively in isolated SAN and atrial myocytes Springer et al. 2012) .
In summary we have used high-resolution optical mapping to study the effects of NPs and the roles of their distinct receptors on activation patterns, electrical conduction and action potential morphology in atrial preparations containing the SAN. Our data provide novel insight into the potent effects of NPs on SAN function and demonstrate that these effects involve multiple receptor subtypes. Few studies have considered how the GC-linked NPRs (NPR-A and NPR-B) and NPR-C can each contribute to the overall effect of NPs in the heart in different physiological conditions. Our data demonstrate that, depending on experimental conditions, these different classes of receptors can simultaneously contribute to the effects of BNP and CNP and this must be considered when interpreting the effects of NPs on cardiac function.
